The First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu, China.
Department of Scientific Research office, Gansu Provincial Hospital, Lanzhou, Gansu, China.
BMJ Open. 2023 Dec 22;13(12):e072244. doi: 10.1136/bmjopen-2023-072244.
Clinical practice guidelines recommend retrieving at least 12 lymph nodes for correct staging in colorectal cancer. However, it is difficult to retrieve adequate lymph nodes because of various factors. We aimed to evaluate the association between the number of retrieved lymph nodes and demographic/tumour-related characteristics in colorectal cancer.
Systematic review and meta-analysis of primary studies.
PubMed, Embase, Cochrane and Web of Science were searched from January 2016 to June 2023.
Studies that evaluated the association between retrieved lymph nodes and demographic/tumour-related characteristics in colorectal cancer were included.
OR with 95% conference intervals was extracted and pooled.
A total of 54 studies containing 2 05 821 patients were included in this meta-analysis. The results showed that fewer nodes were retrieved from elderly patients (OR=0.70, 95% CI (0.54 to 0.90), p=0.005), and from tumours located in the left colon than in the right colon (OR=0.43, 95% CI (0.33 to 0.56), p<0.001). More lymph nodes were obtained from females than males (OR=1.15, 95% CI (1.04 to 1.28), p=0.006), from the advanced T stage (T3+T4) than T1+T2 stage (OR=1.57, 95% CI (1.25 to 1.97), p<0.001) and from the N2 stage than N0 stage (OR=1.32, 95% CI (1.15 to 1.51), p<0.001). Body mass index, ethnicity, N1 stage, M stage, tumour differentiation and lymph-vascular invasion were not significantly associated with the lymph node yield.
The study results suggest that clinicians have an increased opportunity to retrieve sufficient lymph nodes for accurate pathological staging to guide treatment decisions in patients with colorectal cancer who are young, female, with tumours located in the right colon, advanced T stage and N2 stage.
临床实践指南建议在结直肠癌中至少检出 12 个淋巴结以进行正确分期。然而,由于各种因素,很难获得足够的淋巴结。本研究旨在评估在结直肠癌中,检出淋巴结数量与人口统计学/肿瘤相关特征之间的关系。
对原始研究进行系统评价和荟萃分析。
从 2016 年 1 月至 2023 年 6 月,检索了 PubMed、Embase、Cochrane 和 Web of Science。
纳入评估结直肠癌中检出淋巴结数量与人口统计学/肿瘤相关特征之间关系的研究。
提取并汇总比值比(OR)及其 95%置信区间。
本荟萃分析共纳入 54 项包含 205821 例患者的研究。结果显示,老年患者(OR=0.70,95%置信区间(0.54 至 0.90),p=0.005)和左半结肠癌患者(OR=0.43,95%置信区间(0.33 至 0.56),p<0.001)的检出淋巴结较少。女性比男性(OR=1.15,95%置信区间(1.04 至 1.28),p=0.006)、T 分期晚期(T3+T4)比 T1+T2 期(OR=1.57,95%置信区间(1.25 至 1.97),p<0.001)和 N2 期比 N0 期(OR=1.32,95%置信区间(1.15 至 1.51),p<0.001)的检出淋巴结更多。体重指数、种族、N1 期、M 期、肿瘤分化和淋巴血管侵犯与淋巴结检出率无显著相关性。
研究结果表明,在年轻、女性、肿瘤位于右半结肠、T 分期晚期和 N2 期的结直肠癌患者中,临床医生有更多机会获取足够的淋巴结进行准确的病理分期,以指导治疗决策。